Trial Watch

Leading Results Leading Results

Challenged Results Challenged Results

HIV Vaccine Trial HVTN 702 Stopped Early for Non-Efficacy

HIV Vaccine Trial HVTN 702 Stopped Early for Non-Efficacy

The US National Institute of Allergy and Infectious Diseases (National Institute of Allergy & Infectious Diseases (NIAID)) announced that HVTN 702, a large-scale HIV vaccine efficacy trial of a canary pox-based vaccine candidate, has been stopped following an...

subscribe

University at Buffalo
subscribe

Pin It on Pinterest